Lipid Soluble Antioxidants Patented Compound Group
OXIS' LSA molecules are designed to mimic the activity of the body's natural
cell membrane-protecting antioxidant, vitamin E. Molecules from this series
are 20 to 40 fold more potent than vitamin E and move into cell membranes
much more quickly, making them more appropriate as drugs than the natural
vitamin. The primary disease targets for this series of molecules will
include neurodegenerative diseases such as Alzheimer and Parkinson disease
as well as cardiovascular diseases.